# Figure and participant-flow check

- Checker scope: `JAMA2025_9110_D01_MAIN` source PDF pp. 1-10 and result-relevant `JAMA2025_9110_D04_RESULTS_SUPP` source PDF pp. 1-32, using page-linked rendered images and extracted evidence.
- Visuals reviewed: D01 Figures 1-3 (pp. 3, 6, 8); D04 eFigures 1-7 (pp. 23-28), with nearby result tables and main-text claims used only for explicit comparison.
- Additional source-page spot-check renders: `visual_review/D04-p23-4x.png` and `visual_review/D04-p25-4x.png`, corresponding exactly to D04 source PDF pp. 23 and 25.
- Excluded by design: `JAMA2025_9110_D02_PROTOCOL`, `JAMA2025_9110_D03_SAP`, D04 references pp. 33-34, and external sources.
- Allowed categories assessed: `Participant flow inconsistency` and `Presentation inconsistency`.
- Candidate count: 1.

## Candidate FF-01

- **Category:** Presentation inconsistency
- **Short title:** Participant boxes are labeled as patient-level randomization although randomization occurred at the ICU/cluster level
- **Exact visual location:** `jama_summers_2025_oi_250040_1753124024.36498.pdf`, source PDF p. 3, Figure 1, four patient-level treatment boxes.
- **Visible wording:** Figure 1 labels `650 Randomized to augmented protein group`, `703 Randomized to usual protein group`, `1043 Randomized to augmented protein group`, and `1015 Randomized to usual protein group`.
- **Comparison evidence:** In the same figure, the top branches state that `4 ICUs` were randomized to each treatment sequence. D01 p. 2, Methods, states that "ICUs were randomly assigned" and that eligible participants commenced the formula "to which the ICU was randomized." D01 p. 8, Limitations, explicitly states: "randomization occurred at the cluster level rather than the patient level."
- **Logical basis:** The lower boxes visually attribute randomization to individual patients, but the article explicitly identifies ICUs/clusters as the randomization units. The patient counts are arithmetically correct; the candidate concerns only the inconsistent participant-flow terminology. Wording such as "assigned/exposed to" or "included during the augmented/usual-protein period" would distinguish patient treatment allocation from cluster randomization.
- **Confidence:** High (0.97).
- **Concise verification instruction:** Open D01 p. 3 Figure 1 and compare the four lower "Randomized to..." patient boxes with the randomization description on D01 p. 2 and the explicit cluster-vs-patient statement on D01 p. 8; determine whether the patient-box labels should be corrected to cluster-period assignment/exposure language.

## Checks that passed

### D01 Figure 1 participant flow, p. 3

- Sequence beginning usual protein: `683 - 33 = 650` augmented-period participants and `746 - 43 = 703` usual-period participants.
- Sequence beginning augmented protein: `1130 - 87 = 1043`, then `1043 - 12 = 1031`; `1040 - 25 = 1015`, then `1015 - 2 = 1013`.
- Aggregate arithmetic reconciles: assessed `1429 + 2170 = 3599`; initially included/enrolled before consent withdrawals `650 + 703 + 1043 + 1015 = 3411`; consent-data-retention withdrawals `12 + 2 = 14`; primary population `3411 - 14 = 3397`; treatment totals `650 + 1031 = 1681` and `703 + 1013 = 1716`; `1681 + 1716 = 3397`.
- Exclusion subtotals reconcile with each exclusion total: `20 + 9 + 4 = 33`; `32 + 5 + 6 = 43`; `40 + 41 + 6 = 87`; `22 + 3 = 25`.
- These counts agree with the D01 Results population statement and D04 eTable 3 sequence totals (`2044 + 1353 = 3397`).

### D01 Figure 2, p. 6, and D04 eFigure 2/eTable 5, pp. 13 and 23

- Observed-patient annotations at days 1/2/3/4/5/10/20/30 match across the main figure, supplement figure, and eTable 5: augmented `1680/1584/1229/1005/817/341/100/43`; usual `1711/1608/1247/998/823/347/91/34`.
- Legend colors, protein/calorie axes, trial-day labels, box/whisker legend, and the main-text statement of greater protein with similar calories are visually coherent.
- eTable 5 additionally reports day-90 observations (`n=0` augmented, `n=1` usual); their omission from the figures is not presented as a contradictory value and was not retained as an issue.

### D01 Figure 3, p. 8, and D04 eFigure 7, p. 28

- Mechanical-ventilation, new kidney-replacement-therapy/RRT, age, and BMI subgroup counts, medians/IQRs, median differences, 95% CIs, and interaction P values agree across the two forest plots, allowing normal rounding (`.02` vs `.023`, `.11` vs `.106`, `.47` vs `.468`).
- Each complete subgroup partition reconciles to the group totals where data are complete: ventilation `296 + 1385 = 1681` and `361 + 1355 = 1716`; kidney replacement therapy `1559 + 122 = 1681` and `1597 + 119 = 1716`; age `1231 + 450 = 1681` and `1211 + 505 = 1716`.
- Forest-plot direction is coherent with the outcome: negative augmented-minus-usual differences favor usual/control; positive differences favor augmented/treatment. Truncation arrows are present for the RRT-yes CI extending beyond the plotted range.

### D04 eFigure 1, p. 23

- The two four-ICU sequences alternate intervention/control over four 3-month cluster periods and agree with the D01 Figure 1 design.

### D04 eFigures 3-4, pp. 24-25

- Panel titles, legends, IBW/ABW axes, trial-day labels, group colors, and captions consistently distinguish protein from calories and ideal from actual body weight.
- Displayed daily sample counts are aligned with their day labels and repeat consistently between the protein and calorie panels on each page.

### D04 eFigures 5-6, pp. 26-27

- eFigure 5 labels the displayed distribution as days free of the index hospital and alive at day 90, consistent with the stated primary outcome; no visibly ambiguous bar-based contradiction was inferred.
- eFigure 6 reports posterior median difference `-1.50` and 95% credible interval `-3.86 to 0.90`, matching D01 Table 2. Its negative side is labeled harm and positive side benefit, consistent with higher hospital-free days alive being favorable.

## Disposition

- **Retain for evidence verification:** FF-01.
- **Participant-flow numerical inconsistency:** None located.
- **Other figure/flow candidates:** None retained because the visible values, axes, captions, directions, and counts checked were internally consistent or did not support a non-ambiguous contradiction.
